Boehringer Ingelheim Study Coordinator [clinicaltrials_resource:f60a005203c55dd9a26c35275c91672c]
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose [clinicaltrials:NCT00034840]Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients [clinicaltrials:NCT00056641]Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma [clinicaltrials:NCT00096616]Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease [clinicaltrials:NCT00106821]A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions [clinicaltrials:NCT00144248]The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects [clinicaltrials:NCT00146289]A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) [clinicaltrials:NCT00148486]A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) [clinicaltrials:NCT00152958]Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome [clinicaltrials:NCT00152997]An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type [clinicaltrials:NCT00153010]A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) [clinicaltrials:NCT00168792]Tiotropium / Respimat One-Year Study [clinicaltrials:NCT00168831]clinicaltrials:NCT00168844A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) [clinicaltrials:NCT00168857]Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD [clinicaltrials:NCT00239460]12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [clinicaltrials:NCT00239473]12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD [clinicaltrials:NCT00240435]A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients [clinicaltrials:NCT00240448]Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients [clinicaltrials:NCT00274508]Tiotropium (Spiriva) Rehabilitation Study [clinicaltrials:NCT00274521]A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases. [clinicaltrials:NCT00274534]Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [clinicaltrials:NCT00274547]A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. [clinicaltrials:NCT00274560]PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN [clinicaltrials:NCT00274599]PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM) [clinicaltrials:NCT00274638]3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study [clinicaltrials:NCT00275444]Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI) [clinicaltrials:NCT00292435]Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients [clinicaltrials:NCT00294372]An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma [clinicaltrials:NCT00365560]Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment [clinicaltrials:NCT00651183]
overall official [clinicaltrials_vocabulary:overall-official]
Boehringer Ingelheim Study Coordinator [clinicaltrials_resource:f60a005203c55dd9a26c35275c91672c]
Bio2RDF identifier
f60a005203c55dd9a26c35275c91672c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f60a005203c55dd9a26c35275c91672c
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
clintriage.rdg@boehringer-ingelheim.com
last name [clinicaltrials_vocabulary:last-name]
Boehringer Ingelheim Study Coordinator
phone [clinicaltrials_vocabulary:phone]
1-800-243-0127
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:f60a005203c55dd9a26c35275c91672c
title
Boehringer Ingelheim Study Coordinator
@en
type
label
Boehringer Ingelheim Study Coo ...... a005203c55dd9a26c35275c91672c]
@en